Company: LRHC
Filing Date: 2025-09-25
Form Type: S-1
Source: 0001213900-25-091637
Chunk: 46

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-25
Form: S-1
Chunk 46
---
 Period; and (C) an Extended Purchase Pricing Period being the lower of (i) the lowest price the common stock traded
during the Extended Trading Hours (as defined therein) on the trading day applicable to the relevant Pricing Period and (ii) the lowest
Extended Hourly VWAP (as defined therein) of the common shares during the trading day applicable to the relevant.

The proceeds from any sale of Advance Shares by
the Company under the Amended Facility Agreement may be used by the Company in the manner set forth in this Prospectus, including for
working capital purposes for the Company and its subsidiaries. However, neither the Company nor any of its subsidiaries directly or indirectly
will use the proceeds of the transactions contemplated in the Amended Facility Agreement to repay any advances or loans to any executives
or employees of the Company or any subsidiary or to make any payments in respect of any related party obligations, including without limitation
any payables or notes payable to related parties of the Company or any subsidiary.

The Company will control the timing and amount
of any sales of Advance Shares to the Selling Stockholder. Actual sales of Advance Shares under the Facility will depend on a variety
of factors to be determined by the Company from time to time, which may include, without limitation, market conditions, the trading price
of the common stock and determinations by the Company as to the appropriate sources of funding for its business and operational needs.
The net proceeds under the Facility to the Company will depend on the frequency and prices at which the Company sells Advance Shares to
the Selling Stockholder.

The Selling Stockholder will not be required to
subscribe for any Advance Shares under the Amended Facility Agreement which, when aggregated with all other Shares then beneficially owned
by the Selling Stockholder and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act, and Rule 13d-3 promulgated
thereunder), would result in the beneficial ownership by the Selling Stockholder and its affiliates to exceed 4.99% (which the Selling
Stockholder, upon notice to the Company, may increase or decrease but in no event in excess of 9.99%) of the outstanding voting power
or number of the Common Stock. As of August 4, 2025, the Selling Stockholder beneficially owned no shares of our common stock.

The Amended Facility Agreement contains customary
representations, warranties, conditions and indemnification obligations of the parties.

A.G.P./Alliance Global Partners acted as financial
advisor